SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health issues.

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...

No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) without considering cardiovascular and kidney risks, according to a BMJ ...

In 2025, Släcka introduces a functional beverage designed to combat mid-afternoon cravings by offering a healthier ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...

Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

More evidence shows a risk between GLP-1 drugs and vision risks. A study in JAMA Network Open adds more evidence linking ...